Mcconnell Dowell Corporation (MDC.AX)
2ND TIMEFRAME TREND
Trading: SELL @ $0.435
Signal Strength: STRONG
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has been constructed to highlight the existence of a trend for an assocaited timeframe. Trend determining indicators can be used in short, medium or long term timeframes & determines if the stock is trending or ranging. Once the trend status is quantified, this can then be coupled to additional indicators to add a significant advantage to the trading strategy.
Mcconnell Dowell Corporation (ASX:MDC) is in an downtrend in the medium term timeframe. The current rally number is 4 & the highest rally count for the LTM is 43. The highest rally for the month is 13
The Tricklar medium term trend indicator (T2) highlights the peaks and troughs associated with a combination of bars within the first timeframe. As such, successive rallies penetrating preceding higher peaks whilst cancelling preceding low points offer a BULLISH indication in the second time frame. Conversely, failure of rallies to penetrate previous high points whilst maintaining prices below the previous low points indicates BEARISH trends in the second timeframe. The way in which multiple timeframes should be integrated in a complete analysis emphasises an important principle that applies to all technical analysis. The investor should always analyse a market from the big picture down to the level at which trading decisions are made. Trends can exist in many timeframes. Short term trends can therefore be seen together as part of a medium term trend and, in turn, medium trends can be seen together as part of a long term trend.
Calculation: Tricklar medium trend (T2):
1) [BULLISH] An uptrend is a succession of higher peaks and higher troughs;
2) [BEARISH] A downtrend is a succession of lower peaks and lower troughs;
PROFILE: Mcconnell Dowell Corporation (MDC.AX)
Stock Exchange: ASX
Company: Mcconnell Dowell Corporation
Ticker Codes: | MDC.AX | ASX:MDC |
Medlab Clinical Limited, a medical research and development facility, engages in nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. The company has a strategic alliance with Heritage Brands Limited to develop and market its products for the pharmacy retail channel. Medlab Clinical Limited was founded in 2012 and is based in Alexandria, Australia.
2nd timeframe trendDownload
|AYS Amaysim Australia||1.06||9.3||280,426||-1||BEARISH|
|MNS Milnes Holdings||0.31||8.9||461,897||-1||BEARISH|
|BKL Blackmores Laboratories||127.63||8.8||119,034||-1||BEARISH|
|BRN Brainchip Holdings||0.14||8||628,933||-1||BEARISH|
|BGA Bega Cheese||6.51||5.7||1,484,538||-1||BEARISH|